HSD10 disease, infantile type

Get in touch with RARE Concierge.

Contact RARE Concierge

HSD10 disease, infantile type

Synonyms: 2-methyl-3-hydroxybutyric aciduria, classic type | 2-methyl-3-hydroxybutyric aciduria, infantile type | 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency, classic type | 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency, infantile type | HSD10 deficiency, classic type | HSD10 deficiency, infantile type | HSD10 disease, classic type | MHBD deficiency, classic type | MHBD deficiency, infantile type

A clinical subtype of HSD10 disease a rare neurometabolic disorder. Affected boys may show lethargy poor feeding and evidence of mitochondrial dysfunction in the newborn period with subsequent mild developmental delay and abnormal muscle tone. Hallmark of the disease is progressive neurodegeneration and cardiomyopathy which usually manifests between ages 6 months and 2 years with developmental regression progressive visual and hearing loss epilepsy and other neurological symptoms and severe cardiomyopathy. Laboratory investigations show signs of mitochondrial dysfunction and increased urinary excretion of specific isoleucine metabolites. The disease is often fatal around 2-4 years of age.

Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview.

Reference: Access aggregated data from Orphanet at Orphadata.

Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http: //www.orphadata.org. Data version September 2023.

Newly diagnosed with
HSD10 disease, infantile type?

Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.

Get Concierge Help

Advocacy Organizations

Mississippi Metabolics Foundation

Mississippi Metabolics Foundation (MMF) was founded to raise awareness, educate, and provide support to those living or caring for someone with genetic metabolic disorders/inborn errors of metabolism (IEM).

Clinical Trials

For a list of clinical trials in this disease area, please click here.